Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,755 DKK | +0.98% | -1.32% | -18.56% |
06-28 | Would you like some more inflation? | |
06-28 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.56% | 15.99B | |
+16.61% | 121B | |
+17.75% | 110B | |
+17.23% | 25.98B | |
-24.11% | 19.27B | |
-18.47% | 15.66B | |
-47.75% | 14.5B | |
+57.35% | 14.47B | |
+5.62% | 13.91B | |
+125.88% | 10B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Transcript : Genmab A/S, ProfoundBio - M&A Call